Roles of histamine receptors in pain perception: A study using receptors gene knockout mice

Folia Pharmacologica Japonica

Volumn 122, Issue 5, 2003, Pages 391-399

  Yanai, Kazuhiko ^a   Mobarakeh, Jalal Izadi ^a   Kuramasu, Atsuo ^a   Sakurada, Shinobu ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

H1 receptors; H2 receptors; Histamine; Knockout mice; Morphine

Indexed keywords

CAPSAICIN; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE RECEPTOR; MORPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; CHEMOSENSITIVITY; COGNITION; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; ENERGY METABOLISM; FEEDING BEHAVIOR; HETEROZYGOSITY; HOT PLATE TEST; INTERMETHOD COMPARISON; KNOCKOUT GENE; KNOCKOUT MOUSE; MOLECULAR DYNAMICS; MOUSE; NERVE CELL PLASTICITY; NOCICEPTION; NONHUMAN; PSYCHOSIS; REVIEW; SLEEP PATTERN; SPINAL CORD; STIMULUS RESPONSE; STRESS; TAIL FLICK TEST; WAKEFULNESS; WILD TYPE;

ANALGESICS, NON-NARCOTIC; ANIMALS; HISTAMINE H1 ANTAGONISTS; MICE; MICE, KNOCKOUT; MORPHINE; PAIN; PAIN MEASUREMENT; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2;

EID: 0344873264     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.122.391     Document Type: Review

References (44)

1. Scholz J, Woolf CJ. Can we conquer pain?. Nat Neurosci. 2002;Suppl 5:1062-1067.
2. Baranauskas G, Nistri A. Sensitization of pain pathways in the spinal cord: Cellular mechanisms. Prog Neurobiol. 1998;54:349-365.
3. Mason P. Central mechanisms of pain modulation. Curr Opin Neurobiol. 1999;9:436-441.
4. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev. 1991;71:1-51.
5. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol. 2001;63:637-672.
6. Watanabe T, Yanai K. Studies on functional roles of the histaminergic neuron system by using pharmacological agents, knockout mice and positron emission tomography. Tohoku J Exp Med. 2001;195:197-217.
7. Haas HL, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci. 2003;4:121-130.
8. Inoue I, Yanai K, Kitamura D, et al. Impaired locomotor activity and exploratory behaviour in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA. 1996;93:13316-13320.
9. Yanai K, Son LZ, Endou M, et al. Behavioral characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience. 1998;87:479-487.
10. Ohtsu H, Tanaka S, Terui T, et al. Mice lacking histidine-decarboxylase exhibit abnormal mast cells. FEBS Lett. 2001;502:53-56.
11. Kobayashi T, Tonai S, Ishihara Y, Koga R, Okabe S, Watanabe T. Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J Clin Invest. 2000;105:1741-1749.
12. Toyota H, Dugovic C, Koehl M, et al. Behavioral characterization of mice lacking histamine H3 receptors. Mol Pharmacol. 2002;62:389-397.
13. Watanabe T, Taguchi Y, Shiosaka S, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 1984;295:13-25.
14. Rosenthal SR, Minard D. Experiments on histamine as the chemical mediator for cutaneous pain. J Exp Med. 1939;70:415-418.
15. Rosenthal SR. Histamine as the chemical mediator for cutaneous pain. J Invest Dermatol. 1977;69:98-105.
16. th edition. McGraw-Hill: New York; 1991. p. 472-491.
17. Kashiba H, Fukui H, Morikawa Y, Senba, E. Gene expression of histamine H1 receptor in guinea pig primary sensory neurons: a relationship between H1 receptor mRNA-expressing neurons and peptidergic neurons. Mol Brain Res. 1999;66:24-34.
18. B receptor and antagonism by CGP 35348 prevent bicuculline and picrotoxin-induced antinociception. Neuropharmacology. 1992;31:783-791.
19. Jones SL, Gebhart GF. Characterization of co-eruleospinal inhibition of the nociceptive tail-flick reflex in the rat: mediation by spinal α2-adrenoreceptors. Brain Res. 1986;66:315-330.
20. Thoburn KK, Hough LB, Nalwalk JW, Mischler SA. Histamine-induced modulation of nociceptive responses. Pain. 1994;58:29-37.
21. Rumore MM, Schlichting DA. Analgesic effects of antihistaminics. Life Sci. 1985;36:403-416.
22. Yeh SY. The effects of antihistaminic drugs on pentazocine antinociception in the rat. Pharmacol Biochem Behav. 1986;24:925-930.
23. Olsen UB, Eltorp CT, Ingvardsen BK, et al. ReN 1869, a novel tricyclic antihistamine, is active against neurogenic pain and inflammation. Eur J Pharmacol. 2002;435 (1):43-57.
24. Hough LB, Nalwalk JW, Li BY, et al. Novel qualitative structure-activity relationships for the antinociceptive actions of H2 antagonists, H3 antagonists and derivatives. J Pharmacol Exp Ther. 1997;283 (3):1534-1543.
25. Mobarakeh JI, Nalwalk JW, Watanabe T, et al. Improgan antinociception does not require neuronal histamine or histamine receptors. Brain Res. 2003;974 (1-2):146-152.
26. Suh HW, Song DK, Choi YS, Kim YH. Effects of intrathecally injected histamine receptor antagonists on the antinociception induced by morphine, beta-endorphin, and U50,488H administered intrathecally in the mouse. Neuropeptides. 1996;30 (5):485-490.
27. Sakurada S, Orito T, Sakurada C, et al. Possible involvement of tachykinin NK1 and NMDA receptors in histamine-induced hyperalgesia in mice. Eur J Pharmacol. 2002;434:29-34.
28. Sakurada S, Orito T, Furuta S, et al. Intrathecal histamine induced spinally mediated behavioral responses through tachykinin NK1 receptors. Pharmacol Biochem Behav. 2003;74:487-493.
29. Malmberg-Aiello P, Lamberti C, Ipponi A, Bartolini A. Evidence for hypernociception induction following histamine H1 receptor activation in rodents. Life Sci. 1998;63:463-476.
30. Mobarakeh JI, Sakurada S, Katsuyama S, et al. Role of histamine H1 receptor in pain perception: a study of the receptor gene knockout mice. Eur J Pharmacol. 2000;391:81-89.
31. Rumore MM, Schlichting DA. Clinical efficacy of antihistaminics as analgesics. Pain. 1986;25:7-22.
32. Telekes A, Holland RL, Withington DA, Peck AW. Effects of triprolidine and dipipanone in the cold induced pain test, and the central nervous system of healthy volunteers. Br J Clin Pharmacol. 1987;24:43-50.
33. Berthold CW, Dionne RA. Clinical evaluation of H1-receptor and H2-receptor antagonists for acute postoperative pain. J Clin Pharmacol. 1993;33(10):944-948.
34. Hougs W, Skouby AP. The analgesic actions of analgesics, antihistamines and chlorpromazine in volunteers. Acta Pharmacol Toxicol. 1957;13:405-409.
35. Beaver WT, Feise G. Comparison of the analgesic effect of morphine, hydroxyzine and their combination in patients with postoperative pain. Adv Pain Res Ther. 1976;1:553-557.
36. Bellville JW, Dorey F, Capparell D, Knox V, Bauer RO. Analgesic effects of hydroxyzine compared to morphine in man. J Clin Pharmacol. 1979;19:290-296.
37. Mobarakeh JI, Sakurada S, Katsuyama S, et al. Enhanced antinociception by intrathecally-administered morphine in histamine H1 receptor gene knockout mice. Neuropharmacology. 2002;42:1079-1088.
38. Church MK, el-Lati S, Caulfield JP. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol. 1991;94 (1-4):310-318.
39. Nishiobori M, Oishi R, Itoh Y, Saeki K. Morphine-induced changes in histamine dynamics in mouse brain. J Neurochemistry. 1985;45:719-724.
40. Parada CA, Tambeli CH, Cunha FQ, Ferreira SH. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced no-ciception. Neuroscience. 2001;102(4):937-944.
41. Ghelardini C, Galeotti N, Bartolini A. No development of tolerance to analgesia by repeated administration of H1 antagonists. Life Sci. 1998;63 (22):PL 317-322.
42. Raffa RB. Antihistamines as analgesics. J Clin Pharm Ther. 2001;26 (2):81-85.
43. Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K. Imaging of central itch modulation in the human brain using positron emission tomography. Pain. 2003;105:339-346.